H.C. Wainwright Initiates Abeona Therapeutics(ABEO.US) With Buy Rating, Announces Target Price $15

H.C. Wainwright analyst Ram Selvaraju initiates coverage on $Abeona Therapeutics(ABEO.US)$ with a buy rating, and sets the target price at $15.According to TipRanks data, the analyst has a success rat

Futu NewsJul 3 18:31 · Ratings

Buy Rating Affirmed for Abeona Therapeutics on Promising Pz-cel Therapy for RDEB

TipRanksJul 3 18:16

Express News | Abeona Therapeutics Inc : H.c. Wainwright Initiates Coverage With Buy Rating; Target Price $15

BreakingsJul 3 18:05

Abeona Therapeutics Independent Director Mark Alvino Sells 41% Of Holding

We'd be surprised if Abeona Therapeutics Inc. (NASDAQ:ABEO) shareholders haven't noticed that the Independent Director, Mark Alvino, recently sold US$117k worth of stock at US$4.51 per share. That

Simply Wall StJun 25 02:41

Insider Sale: Director Christine Silverstein Sells Shares of Abeona Therapeutics Inc (ABEO)

Yahoo FinanceJun 21 15:08

Abeona Therapeutics(ABEO.US) Director Sells US$116.76K in Common Stock

$Abeona Therapeutics(ABEO.US)$ Director Alvino Mark sold 25,890 shares of common stock on Jun 18, 2024 at an average price of $4.51 for a total value of $116.76K.Source: Announcement What is statement

Futu NewsJun 21 05:14